IL125072A - HISTORY OF PYRIDO - 4,2,1 thiodiazine-3 amine and pharmaceutical preparations containing them - Google Patents

HISTORY OF PYRIDO - 4,2,1 thiodiazine-3 amine and pharmaceutical preparations containing them

Info

Publication number
IL125072A
IL125072A IL12507297A IL12507297A IL125072A IL 125072 A IL125072 A IL 125072A IL 12507297 A IL12507297 A IL 12507297A IL 12507297 A IL12507297 A IL 12507297A IL 125072 A IL125072 A IL 125072A
Authority
IL
Israel
Prior art keywords
alkyl
alkoxy
cycloalkyl
halogen
hydroxy
Prior art date
Application number
IL12507297A
Other languages
English (en)
Hebrew (he)
Other versions
IL125072A0 (en
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL125072A0 publication Critical patent/IL125072A0/xx
Publication of IL125072A publication Critical patent/IL125072A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
IL12507297A 1996-01-17 1997-01-16 HISTORY OF PYRIDO - 4,2,1 thiodiazine-3 amine and pharmaceutical preparations containing them IL125072A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DK4296 1996-01-17
DK24696 1996-03-05
DK24996 1996-03-05
DK24796 1996-03-05
DK24896 1996-03-05
PCT/DK1997/000018 WO1997026264A1 (en) 1996-01-17 1997-01-16 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use

Publications (2)

Publication Number Publication Date
IL125072A0 IL125072A0 (en) 1999-01-26
IL125072A true IL125072A (en) 2002-12-01

Family

ID=27512741

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12507297A IL125072A (en) 1996-01-17 1997-01-16 HISTORY OF PYRIDO - 4,2,1 thiodiazine-3 amine and pharmaceutical preparations containing them

Country Status (16)

Country Link
US (1) US5792764A (ru)
EP (1) EP0877748B1 (ru)
JP (1) JP2000503651A (ru)
KR (1) KR19990077320A (ru)
CN (1) CN1208418A (ru)
AT (1) ATE281460T1 (ru)
AU (1) AU727905B2 (ru)
BR (1) BR9707004A (ru)
CA (1) CA2241565A1 (ru)
CZ (1) CZ220598A3 (ru)
DE (1) DE69731458T2 (ru)
IL (1) IL125072A (ru)
NO (1) NO983285L (ru)
PL (1) PL327927A1 (ru)
RU (1) RU2193564C2 (ru)
WO (1) WO1997026264A1 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329368B1 (en) * 1997-05-09 2001-12-11 The Regents Of The University Of California Endocrine modulation with positive modulators of AMPA type glutamate receptors
WO1999032495A1 (en) * 1997-12-19 1999-07-01 Novo Nordisk A/S Pyrido 1,2,4-thiadiazine derivatives, their preparation and use
AU2001265839A1 (en) * 2000-06-26 2002-01-08 Novo-Nordisk A/S Use of potassium channel agonists for the treatment of cancer
US20030109519A1 (en) * 2001-11-30 2003-06-12 Jeppe Sturis Use of selective potassium channel openers
AU2002342600A1 (en) * 2001-11-30 2003-06-10 Novo Nordisk A/S Use of selective potassium channel openers
AU2002365289A1 (en) * 2001-11-30 2003-06-10 Novo Nordisk A/S Use of selective potassium channel openers
AU2003232171A1 (en) * 2002-06-14 2003-12-31 Novo Nordisk A/S Combined use of a modulator of cd3 and a beta cell resting compound
US9533999B2 (en) 2012-06-21 2017-01-03 Boehringer Ingelheim International Gmbh Fused thiazin-3-ones as KCA3.1 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1368948A (en) * 1970-11-11 1974-10-02 Manuf Prod Pharma Pyridine derivatives
FR2703051B1 (fr) * 1993-03-26 1995-04-28 Adir Nouvelles pyridothiadiazines, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
PL327927A1 (en) 1999-01-04
EP0877748A1 (en) 1998-11-18
BR9707004A (pt) 1999-07-20
RU2193564C2 (ru) 2002-11-27
IL125072A0 (en) 1999-01-26
WO1997026264A1 (en) 1997-07-24
CA2241565A1 (en) 1997-07-24
NO983285D0 (no) 1998-07-16
EP0877748B1 (en) 2004-11-03
AU1437097A (en) 1997-08-11
DE69731458T2 (de) 2005-12-22
DE69731458D1 (de) 2004-12-09
ATE281460T1 (de) 2004-11-15
AU727905B2 (en) 2001-01-04
JP2000503651A (ja) 2000-03-28
CZ220598A3 (cs) 1998-12-16
NO983285L (no) 1998-09-16
KR19990077320A (ko) 1999-10-25
CN1208418A (zh) 1999-02-17
US5792764A (en) 1998-08-11

Similar Documents

Publication Publication Date Title
AU727775B2 (en) Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
AU757693B2 (en) Fused 1,2,4-thiadiazine derivatives, their preparation and use
US6225310B1 (en) Fused 1,2,4-thiadiazine derivatives, their preparation and use
EP1140945B1 (en) Fused 1,2,4-thiadiazine derivatives, their preparation and use
AU737920B2 (en) 1,2,4-benzothiadiazine derivatives, their preparation and use
IL125072A (en) HISTORY OF PYRIDO - 4,2,1 thiodiazine-3 amine and pharmaceutical preparations containing them
WO1999032495A1 (en) Pyrido 1,2,4-thiadiazine derivatives, their preparation and use
US6329367B1 (en) Fused 1,2,4-thiadiazine derivatives, their preparation and use
WO1999032467A1 (en) 1,2,4-benzothiadiazine derivatives, their preparation and use
RU2199542C2 (ru) Производные конденсированного 1,2,4-тиадиазина и конденсированного 1,4-тиазина, их получение и использование
WO1999032494A1 (en) Fused 1,2,4-thiadiazine derivatives, their preparation and use
CZ200044A3 (cs) Kondenzovaný 1,4-thiazinový derivát, způsob jeho výroby a farmaceutický prostředek ho f obsahující
MXPA01006224A (en) Fused 1,2,4-thiadiazine derivatives, their preparation and use

Legal Events

Date Code Title Description
FF Patent granted
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees